GANX
Price
$1.91
Change
-$0.02 (-1.04%)
Updated
May 14, 02:02 PM (EDT)
Capitalization
56.79M
Earnings call today
MGTX
Price
$4.67
Change
-$0.47 (-9.13%)
Updated
May 14, 02:19 PM (EDT)
Capitalization
411.75M
85 days until earnings call
Ad is loading...

GANX vs MGTX

Header iconGANX vs MGTX Comparison
Open Charts GANX vs MGTXBanner chart's image
Gain Therapeutics
Price$1.91
Change-$0.02 (-1.04%)
Volume$2.51K
Capitalization56.79M
MeiraGTx Holdings
Price$4.67
Change-$0.47 (-9.13%)
Volume$815
Capitalization411.75M
GANX vs MGTX Comparison Chart
Loading...
GANX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GANX vs. MGTX commentary
May 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GANX is a Hold and MGTX is a Hold.

Ad is loading...
COMPARISON
Comparison
May 14, 2025
Stock price -- (GANX: $1.93 vs. MGTX: $5.15)
Brand notoriety: GANX and MGTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GANX: 48% vs. MGTX: 132%
Market capitalization -- GANX: $56.79M vs. MGTX: $411.75M
GANX [@Biotechnology] is valued at $56.79M. MGTX’s [@Biotechnology] market capitalization is $411.75M. The market cap for tickers in the [@Biotechnology] industry ranges from $295.2B to $0. The average market capitalization across the [@Biotechnology] industry is $2.14B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GANX’s FA Score shows that 0 FA rating(s) are green whileMGTX’s FA Score has 0 green FA rating(s).

  • GANX’s FA Score: 0 green, 5 red.
  • MGTX’s FA Score: 0 green, 5 red.
According to our system of comparison, MGTX is a better buy in the long-term than GANX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GANX’s TA Score shows that 6 TA indicator(s) are bullish while MGTX’s TA Score has 3 bullish TA indicator(s).

  • GANX’s TA Score: 6 bullish, 4 bearish.
  • MGTX’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, GANX is a better buy in the short-term than MGTX.

Price Growth

GANX (@Biotechnology) experienced а +2.12% price change this week, while MGTX (@Biotechnology) price change was -12.27% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.95%. For the same industry, the average monthly price growth was +6.81%, and the average quarterly price growth was -5.99%.

Reported Earning Dates

GANX is expected to report earnings on Aug 07, 2025.

MGTX is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+0.95% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MGTX($412M) has a higher market cap than GANX($56.8M). GANX YTD gains are higher at: -10.648 vs. MGTX (-15.435). GANX has higher annual earnings (EBITDA): -21.34M vs. MGTX (-121.84M). MGTX has more cash in the bank: 104M vs. GANX (12M). GANX has less debt than MGTX: GANX (769K) vs MGTX (84.8M). MGTX has higher revenues than GANX: MGTX (33.3M) vs GANX (0).
GANXMGTXGANX / MGTX
Capitalization56.8M412M14%
EBITDA-21.34M-121.84M18%
Gain YTD-10.648-15.43569%
P/E RatioN/AN/A-
Revenue033.3M-
Total Cash12M104M12%
Total Debt769K84.8M1%
FUNDAMENTALS RATINGS
MGTX: Fundamental Ratings
MGTX
OUTLOOK RATING
1..100
62
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
58
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GANXMGTX
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
82%
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 7 days ago
79%
Bullish Trend 14 days ago
81%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 8 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
74%
View a ticker or compare two or three
Ad is loading...
GANX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA334.0715.69
+4.93%
Tesla
BTC.X104169.8100001356.851600
+1.32%
Bitcoin cryptocurrency
GME28.390.34
+1.21%
GameStop Corp
AAPL212.932.14
+1.02%
Apple
SPY586.843.85
+0.66%
SPDR® S&P 500® ETF

GANX and

Correlation & Price change

A.I.dvisor indicates that over the last year, GANX has been loosely correlated with COYA. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if GANX jumps, then COYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GANX
1D Price
Change %
GANX100%
+0.52%
COYA - GANX
33%
Loosely correlated
-6.19%
VXRT - GANX
32%
Poorly correlated
+2.59%
MGTX - GANX
31%
Poorly correlated
-8.36%
CGEM - GANX
29%
Poorly correlated
-3.67%
SGMT - GANX
27%
Poorly correlated
-3.93%
More

MGTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MGTX has been loosely correlated with RGNX. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if MGTX jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MGTX
1D Price
Change %
MGTX100%
-8.36%
RGNX - MGTX
50%
Loosely correlated
+2.63%
AURA - MGTX
48%
Loosely correlated
-1.68%
KRRO - MGTX
47%
Loosely correlated
-2.69%
IDYA - MGTX
47%
Loosely correlated
-4.90%
BEAM - MGTX
45%
Loosely correlated
-1.04%
More